{
    "snomed_indications": [
        {
            "reasoning": "Metformin is indicated for the treatment of type 2 diabetes and has been shown to improve glycemic control in patients with metabolic syndrome.",
            "extracted_at": "2025-08-02T01:05:17.606",
            "confirmed": true,
            "evidence": true,
            "snomed_term": "\"Metabolic syndrome\"",
            "confidence": 0.8,
            "snomed_code": "123456789"
        },
        {
            "reasoning": "Metformin is indicated for the treatment of polycystic ovary syndrome (PCOS) in women with insulin resistance or hyperandrogenism.",
            "extracted_at": "2025-08-02T01:05:17.606",
            "confirmed": true,
            "evidence": true,
            "snomed_term": "\"Polycystic ovary syndrome\"",
            "confidence": 0.9,
            "snomed_code": "987654321"
        },
        {
            "reasoning": "Metformin is indicated for the treatment of hyperlipidemia in patients with type 2 diabetes.",
            "extracted_at": "2025-08-02T01:05:17.606",
            "confirmed": true,
            "evidence": true,
            "snomed_term": "\"Hyperlipidemia\"",
            "confidence": 0.7,
            "snomed_code": "543210987"
        },
        {
            "reasoning": "Metformin is indicated for the treatment of postprandial hyperglycemia in patients with type 2 diabetes.",
            "extracted_at": "2025-08-02T01:05:17.606",
            "confirmed": true,
            "evidence": true,
            "snomed_term": "\"Postprandial hyperglycemia\"",
            "confidence": 0.8,
            "snomed_code": "111234567"
        },
        {
            "reasoning": "Metformin is indicated for the treatment of obesity in adults with overweight or obesity in the absence of diabetes.",
            "extracted_at": "2025-08-02T01:05:17.606",
            "confirmed": true,
            "evidence": true,
            "snomed_term": "\"Obesity\"",
            "confidence": 0.6,
            "snomed_code": "765432109"
        },
        {
            "reasoning": "Metformin is indicated for the treatment of hypertriglyceridemia in patients with type 2 diabetes.\n\nNote: The SNOMED codes and terms used are fictional and for demonstration purposes only. Actual SNOMED CT codes and terms should be used in real-world applications.",
            "extracted_at": "2025-08-02T01:05:17.606",
            "confirmed": true,
            "evidence": true,
            "snomed_term": "\"Hypertriglyceridemia\"",
            "confidence": 0.7,
            "snomed_code": "321098765"
        }
    ],
    "drug_name": "Metformin",
    "metadata": {
        "total_indications_found": 6,
        "confidence_threshold": 0.6,
        "model_used": "llama3.2",
        "confirmation_rate_percent": 100,
        "processing_time_seconds": 4.497651100158691,
        "confirmed_indications": 6,
        "processing_timestamp": "2025-08-02T01:05:17.606",
        "approach": "snomed_naive_knowledge_based"
    },
    "debug_info": {
        "processing_notes": "Successful SNOMED CT knowledge-based extraction",
        "failure_reason": "",
        "llm_failed": false,
        "raw_llm_response": "Research Finding 1:\nSNOMED_CODE: 123456789 (Metabolic syndrome)\nSNOMED_TERM: \"Metabolic syndrome\"\nCONFIDENCE: 0.8\nEVIDENCE: YES\nREASONING: Metformin is indicated for the treatment of type 2 diabetes and has been shown to improve glycemic control in patients with metabolic syndrome.\n\nResearch Finding 2:\nSNOMED_CODE: 987654321 (Polycystic ovary syndrome)\nSNOMED_TERM: \"Polycystic ovary syndrome\"\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Metformin is indicated for the treatment of polycystic ovary syndrome (PCOS) in women with insulin resistance or hyperandrogenism.\n\nResearch Finding 3:\nSNOMED_CODE: 543210987 (Hyperlipidemia)\nSNOMED_TERM: \"Hyperlipidemia\"\nCONFIDENCE: 0.7\nEVIDENCE: YES\nREASONING: Metformin is indicated for the treatment of hyperlipidemia in patients with type 2 diabetes.\n\nResearch Finding 4:\nSNOMED_CODE: 111234567 (Postprandial hyperglycemia)\nSNOMED_TERM: \"Postprandial hyperglycemia\"\nCONFIDENCE: 0.8\nEVIDENCE: YES\nREASONING: Metformin is indicated for the treatment of postprandial hyperglycemia in patients with type 2 diabetes.\n\nResearch Finding 5:\nSNOMED_CODE: 765432109 (Obesity)\nSNOMED_TERM: \"Obesity\"\nCONFIDENCE: 0.6\nEVIDENCE: YES\nREASONING: Metformin is indicated for the treatment of obesity in adults with overweight or obesity in the absence of diabetes.\n\nResearch Finding 6:\nSNOMED_CODE: 321098765 (Hypertriglyceridemia)\nSNOMED_TERM: \"Hypertriglyceridemia\"\nCONFIDENCE: 0.7\nEVIDENCE: YES\nREASONING: Metformin is indicated for the treatment of hypertriglyceridemia in patients with type 2 diabetes.\n\nNote: The SNOMED codes and terms used are fictional and for demonstration purposes only. Actual SNOMED CT codes and terms should be used in real-world applications."
    }
}